Published in Gene Therapy Weekly, March 8th, 2001
In two studies published in the February 2001 issue of Molecular Cell, researchers led by Alan D'Andrea, MD, of Dana-Farber Cancer Institute, Boston, Massachusetts, show how genes involved in a condition called Fanconi anemia form a "pathway" to the activation of BRCA1. If BRCA1 or any of the Fanconi genes are abnormal, the risk of cancer increases dramatically.
"There's strong evidence that under normal conditions, BRCA1...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly